265 related articles for article (PubMed ID: 27530750)
1. Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.
Lambour J; Naranjo-Gomez M; Piechaczyk M; Pelegrin M
Emerg Microbes Infect; 2016 Aug; 5(8):e92. PubMed ID: 27530750
[TBL] [Abstract][Full Text] [Related]
2. A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.
Michaud HA; Gomard T; Gros L; Thiolon K; Nasser R; Jacquet C; Hernandez J; Piechaczyk M; Pelegrin M
PLoS Pathog; 2010 Jun; 6(6):e1000948. PubMed ID: 20548955
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
Pelegrin M; Naranjo-Gomez M; Piechaczyk M
Trends Microbiol; 2015 Oct; 23(10):653-665. PubMed ID: 26433697
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.
Nasser R; Pelegrin M; Michaud HA; Plays M; Piechaczyk M; Gros L
J Virol; 2010 Oct; 84(19):10169-81. PubMed ID: 20610721
[TBL] [Abstract][Full Text] [Related]
5. Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy.
Gros L; Pelegrin M; Plays M; Piechaczyk M
J Virol; 2006 Oct; 80(20):10191-200. PubMed ID: 17005696
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies in diseases of viral origin].
Aguilar Setién A; Kretschmer R
Salud Publica Mex; 1985; 27(3):251-9. PubMed ID: 2996158
[No Abstract] [Full Text] [Related]
7. Monoclonal antibodies for prophylactic and therapeutic use against viral infections.
Both L; Banyard AC; van Dolleweerd C; Wright E; Ma JK; Fooks AR
Vaccine; 2013 Mar; 31(12):1553-9. PubMed ID: 23370150
[TBL] [Abstract][Full Text] [Related]
8. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.
Keeler SP; Fox JM
Viruses; 2021 May; 13(6):. PubMed ID: 34072720
[TBL] [Abstract][Full Text] [Related]
9. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
Schlesinger JJ; Foltzer M; Chapman S
Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
[TBL] [Abstract][Full Text] [Related]
10. Bispecific antibodies for viral immunotherapy.
Nyakatura EK; Soare AY; Lai JR
Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
[TBL] [Abstract][Full Text] [Related]
11. Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus.
Moi ML; Ami Y; Shirai K; Lim CK; Suzaki Y; Saito Y; Kitaura K; Saijo M; Suzuki R; Kurane I; Takasaki T
Am J Trop Med Hyg; 2015 Feb; 92(2):370-6. PubMed ID: 25548383
[TBL] [Abstract][Full Text] [Related]
12. New technologies in therapeutic antibody development: The next frontier for treating infectious diseases.
Keating SM; Higgins BW
Antiviral Res; 2024 Jul; 227():105902. PubMed ID: 38734210
[TBL] [Abstract][Full Text] [Related]
13. Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses.
Pelegrin M; Marsile-Medun S; Abba-Moussa D; Souchard M; Naranjo-Gomez M
Antibodies (Basel); 2022 Jul; 11(3):. PubMed ID: 35892710
[TBL] [Abstract][Full Text] [Related]
14. Humoral and cytotoxic T cell immune responses to internal and external structural proteins of simian virus 5 induced by immunization with solid matrix-antibody-antigen complexes.
Randall RE; Young DF
J Gen Virol; 1988 Oct; 69 ( Pt 10)():2505-16. PubMed ID: 3262715
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of chemiluminescence in bovine polymorphonuclear leucocytes by virus-antibody complexes and by antibody-coated infected cells.
Weber L; Peterhans E
Immunobiology; 1983 May; 164(5):333-42. PubMed ID: 6307864
[TBL] [Abstract][Full Text] [Related]
17. Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen.
Craig ML; Reinagel ML; Martin EN; Schlimgen R; Nardin A; Taylor RP
Clin Immunol; 1999 Aug; 92(2):170-80. PubMed ID: 10444361
[TBL] [Abstract][Full Text] [Related]
18. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen.
Hanke T; Szawlowski P; Randall RE
J Gen Virol; 1992 Mar; 73 ( Pt 3)():653-60. PubMed ID: 1372038
[TBL] [Abstract][Full Text] [Related]
19. Humanized antibodies with broad-spectrum neutralization to avian influenza virus H5N1.
Chen Y; Luo W; Wu WL; Fang Z; Xia L; Gui X; Chen Y; Chen H; Shih JW; Xia N
Antiviral Res; 2010 Jul; 87(1):81-4. PubMed ID: 20450935
[TBL] [Abstract][Full Text] [Related]
20. Human antibody technology and the development of antibodies against cytomegalovirus.
Ohlin M; Söderberg-Nauclér C
Mol Immunol; 2015 Oct; 67(2 Pt A):153-70. PubMed ID: 25802091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
